163 related articles for article (PubMed ID: 17904534)
1. The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells.
Herst PM; Petersen T; Jerram P; Baty J; Berridge MV
Biochem Pharmacol; 2007 Dec; 74(11):1587-95. PubMed ID: 17904534
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells.
De Luca T; Morré DM; Morré DJ
J Cell Biochem; 2010 Aug; 110(6):1504-11. PubMed ID: 20518072
[TBL] [Abstract][Full Text] [Related]
3. Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells.
Kamsteeg M; Rutherford T; Sapi E; Hanczaruk B; Shahabi S; Flick M; Brown D; Mor G
Oncogene; 2003 May; 22(17):2611-20. PubMed ID: 12730675
[TBL] [Abstract][Full Text] [Related]
4. The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells.
Herst PM; Davis JE; Neeson P; Berridge MV; Ritchie DS
Haematologica; 2009 Jul; 94(7):928-34. PubMed ID: 19535345
[TBL] [Abstract][Full Text] [Related]
5. Downstream targets of altered sphingolipid metabolism in response to inhibition of ENOX2 by phenoxodiol.
De Luca T; Bosneaga E; Morré DM; Morré DJ
Biofactors; 2008; 34(3):253-60. PubMed ID: 19734127
[TBL] [Abstract][Full Text] [Related]
6. Mouse embryonic fibroblast cells from transgenic mice overexpressing tNOX exhibit an altered growth and drug response phenotype.
Yagiz K; Wu LY; Kuntz CP; James Morré D; Morré DM
J Cell Biochem; 2007 May; 101(2):295-306. PubMed ID: 17115410
[TBL] [Abstract][Full Text] [Related]
7. ECTO-NOX target for the anticancer isoflavene phenoxodiol.
Morré DJ; Chueh PJ; Yagiz K; Balicki A; Kim C; Morré DM
Oncol Res; 2007; 16(7):299-312. PubMed ID: 17518268
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines.
Aissat N; Le Tourneau C; Ghoul A; Serova M; Bieche I; Lokiec F; Raymond E; Faivre S
Cancer Chemother Pharmacol; 2008 Jul; 62(2):305-13. PubMed ID: 17912526
[TBL] [Abstract][Full Text] [Related]
9. Phenoxodiol, a novel approach for the treatment of ovarian cancer.
Mor G; Fu HH; Alvero AB
Curr Opin Investig Drugs; 2006 Jun; 7(6):542-8. PubMed ID: 16784025
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of a doxorubicin-inhibited NADH-quinone (NADH-ferricyanide) reductase from rat liver plasma membranes.
Kim C; Crane FL; Faulk WP; Morré DJ
J Biol Chem; 2002 May; 277(19):16441-7. PubMed ID: 11875069
[TBL] [Abstract][Full Text] [Related]
11. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
12. Immune modulation and apoptosis induction: Two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera.
Malik F; Kumar A; Bhushan S; Mondhe DM; Pal HC; Sharma R; Khajuria A; Singh S; Singh G; Saxena AK; Suri KA; Qazi GN; Singh J
Eur J Cancer; 2009 May; 45(8):1494-509. PubMed ID: 19269163
[TBL] [Abstract][Full Text] [Related]
13. The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
Kluger HM; McCarthy MM; Alvero AB; Sznol M; Ariyan S; Camp RL; Rimm DL; Mor G
J Transl Med; 2007 Jan; 5():6. PubMed ID: 17257402
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibitory activity of a novel lectin from Cliona varians against K562 human erythroleukemia cells.
Queiroz AF; Silva RA; Moura RM; Dreyfuss JL; Paredes-Gamero EJ; Souza AC; Tersariol IL; Santos EA; Nader HB; Justo GZ; de Sales MP
Cancer Chemother Pharmacol; 2009 May; 63(6):1023-33. PubMed ID: 18781302
[TBL] [Abstract][Full Text] [Related]
15. 4-hydroperoxy-cyclophosphamide mediates caspase-independent T-cell apoptosis involving oxidative stress-induced nuclear relocation of mitochondrial apoptogenic factors AIF and EndoG.
Strauss G; Westhoff MA; Fischer-Posovszky P; Fulda S; Schanbacher M; Eckhoff SM; Stahnke K; Vahsen N; Kroemer G; Debatin KM
Cell Death Differ; 2008 Feb; 15(2):332-43. PubMed ID: 18034189
[TBL] [Abstract][Full Text] [Related]
16. FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in prostate epithelial cells.
Nastiuk KL; Yoo K; Lo K; Su K; Yeung P; Kutaka J; Danielpour D; Krolewski JJ
Mol Cancer Res; 2008 Feb; 6(2):231-42. PubMed ID: 18314484
[TBL] [Abstract][Full Text] [Related]
17. Antimycin A as a mitochondrial electron transport inhibitor prevents the growth of human lung cancer A549 cells.
Han YH; Kim SH; Kim SZ; Park WH
Oncol Rep; 2008 Sep; 20(3):689-93. PubMed ID: 18695925
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells.
Alvero AB; O'Malley D; Brown D; Kelly G; Garg M; Chen W; Rutherford T; Mor G
Cancer; 2006 Feb; 106(3):599-608. PubMed ID: 16388521
[TBL] [Abstract][Full Text] [Related]
19. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
20. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
Yang BF; Xiao C; Li H; Yang SJ
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
